Apothecary Pharma LLC recalls Apothecary NAD+ Injection 200 mg/mL
- Recalling company
- Apothecary Pharma LLC
- Product
- Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Sep 24, 2026
- Reported
- Oct 14, 2026
- Distribution
- Nationwide within the United States
- Status
- Ongoing
- Quantity
- 1 vial
- Lot / codes
- Lot #: AP-202647, BUD 13-Oct-2026
- Company location
- Cary, NC
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0037-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0037-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.